FLUDARABINE PHOSPHATE

LOE Approaching

fludarabine phosphate

NDAINJECTIONINJECTABLE
Approved
Sep 2007
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
3

Clinical Trials (3)

NCT01163357Phase 1Completed

Bortezomib, Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant For High-Risk Stage I or II Multiple Myeloma

Started Jan 2011
NCT00185445Phase 2Completed

Efficacy and Safety Study of Oral Fludarabine Phosphate in Combination With Mitoxantrone as First Line Treatment in Follicular NHL

Started Jun 2004
62 enrolled
Non Hodgkin Lymphoma
NCT00220311Phase 4Completed

A Study to Confirm the Efficacy and Safety of Fludarabine Phosphate Administered in Untreated Chronic Lymphocytic Leukemia Patients With Anemia and/or Thrombocytopenia

Started Nov 2000
10 enrolled
Leukemia, Lymphocytic, Chronic, B-Cell